The NICE NG12 Guideline – A FIT Outcome

During ACB Focus 2016 an Industry Sponsored Workshop (ISW) was held by Alpha Laboratories entitled ‘The NICE NG12 Guideline – A FIT Outcome’. This included presentations from Professor Callum Fraser, Dr Ian Godber and Mr Paul Skaife. They discussed the impact of NICE NG12 on the patient pathway for suspected Lower GI cancer, since the recommendation of FOBT resulted in considerable debate about what test should be offered.  The questions raised about FIT include:

• Where in the patient pathways should such tests be implemented?
• How would this impact patient referrals?
• How would this affect the NHS 2 week wait guidelines?
• What impact would this have on patient outcomes?

A lively Question and Answer session with the audience followed.